In summary, our findings suggest an independent association between decreased SOD activity and MS as well as possible mediating effect of impaired insulin sensitivity and β-cell dysfunction on the relationship between decreased SOD activity and MS. The gene discussed is SOD1; the disease is myeloid sarcoma.